March 11, 2016
1 min read

FDA approves first generic of Oxistat cream, 1% for athlete's foot, jock itch and ringworm

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The FDA announced the approval for the first generic of Oxistat cream, 1% for treating athlete’s foot, jock itch, ringworm and tinea versicolor due to Malassezia furfur.

Common side effects of oxiconazole nitrate cream, 1% reported in clinical trials included pruritus, burning, irritation and allergic contact dermatitis, folliculitis, erythema, and papules, fissure, maceration, rash, stinging, and nodules, according to a drug information update from the FDA.

A medication guide for patients is required for the dispensing of Oxistat cream, which must be used as directed by a physician and is for external dermal use only, according to the update.

Patients should notify a physician if there is no improvement after 2 to 4 weeks, or sooner if the condition worsens or there are signs of increased irritation, itching, blistering, swelling or oozing, the FDA reported. The drug label contains additional information on oxiconazole nitrate cream, 1%, with drug labels of FDA approved drug products searchable at Drugs@FDA.